Resveratrol attenuates methylglyoxal-induced mitochondrial dysfunction and apoptosis by Sestrin2 induction

Toxicology and Applied Pharmacology

Volumn 280, Issue 2, 2014, Pages 314-322

  Seo, Kyuhwa ^a   Seo, Suho ^a   Han, Jae Yun ^a   Ki, Sung Hwan ^a   Shin, Sang Mi ^a  

^a Chosun University   (South Korea)

Author keywords

Methylglyoxal; Mitochondrial dysfunction; Oxidative stress; Reactive oxygen species; Resveratrol; Sestrin2

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; METHYLGLYOXAL; PROTEIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SESTRIN2 PROTEIN; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; NUCLEAR PROTEIN; SESN2 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; ADENOVIRIDAE; ANIMAL; DRUG EFFECTS; GENETICS; HEPG2 CELL LINE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MITOCHONDRION; PHYSIOLOGY; TOXICITY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; GLYCOSYLATION END PRODUCTS, ADVANCED; HEP G2 CELLS; HUMANS; MALE; MICE; MICE, INBRED ICR; MITOCHONDRIA; NUCLEAR PROTEINS; PYRUVALDEHYDE; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84907842559     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.08.011     Document Type: Article

References (62)

1. Akhand A.A., Hossain K., Mitsui H., Kato M., Miyata T., Inagi R., Du J., Takeda K., Kawamoto Y., Suzuki H., Kurokawa K., Nakashima I. Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radic. Biol. Med. 2001, 31:20-30.
2. Aronson D., Rayfield E. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc. Diabetol. 2002, 1:1.
3. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
4. Beisswenger P.J., Howell S.K., Touchette A.D., Lal S., Szwergold B.S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 1999, 48:198-202.
5. Ben-Sahra I., Dirat B., Laurent K., Puissant A., Auberger P., Budanov A., Tanti J.F., Bost F. Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death. Cell Death Differ. 2013, 20:611-619.
6. Biswas S., Ray M., Misra S., Dutta D.P., Ray S. Selective inhibition of mitochondrial respiration and glycolysis in human leukaemic leucocytes by methylglyoxal. Biochem. J. 1997, 323:343-348.
7. Brouwers O., Niessen P.M., Ferreira I., Miyata T., Scheffer P.G., Teerlink T., Schrauwen P., Brownlee M., Stehouwer C.D., Schalkwijk C.G. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J. Biol. Chem. 2011, 286:1374-1380.
8. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 46:223-234.
9. Budanov A.V., Karin M. p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008, 134:451-460.
10. Budanov A.V., Shoshani T., Faerman A., Zelin E., Kamer I., Kalinski H., Gorodin S., Fishman A., Chajut A., Einat P., Skaliter R., Gudkov A.V., Chumakov P.M., Feinstein E. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 2002, 21:6017-6031.
11. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000, 49:27-29.
12. Chen C.-Y., Jang J.-H., Li M.-H., Surh Y.-J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun. 2005, 331:993-1000.
13. Cheng A.-S., Cheng Y.-H., Chiou C.-H., Chang T.-L. Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. J. Agric. Food Chem. 2012, 60:9180-9187.
14. Choudhary D., Chandra D., Kale R.K. Influence of methylglyoxal on antioxidant enzymes and oxidative damage. Toxicol. Lett. 1997, 93:141-152.
15. Fiory F., Lombardi A., Miele C., Giudicelli J., Beguinot F., Obberghen E. Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia 2011, 54:2941-2952.
16. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114:1752-1761.
17. Gabbay K.H. Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Annu. Rev. Med. 1975, 26:521-536.
18. Gaens K.H., Stehouwer C.D., Schalkwijk C.G. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Curr. Opin. Lipidol. 2013, 24:4-11.
19. Garay-Sevilla M.E., Regalado J.C., Malacara J.M., Nava L.E., Wrobel-Zasada K., Castro-Rivas A., Wrobel K. Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus. J. Endocrinol. Investig. 2005, 28:223-230.
20. Higuchi M., Proske R.J., Yeh E.T. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 1998, 17:2515-2524.
21. Hou X., Xu S., Maitland-Toolan K.A., Sato K., Jiang B., Ido Y., Lan F., Walsh K., Wierzbicki M., Verbeuren T.J., Cohen R.A., Zang M. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 2008, 283:20015-20026.
22. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.-L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
23. Hsieh T.-c, Lu X., Wang Z., Wu J.M. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med. Chem. 2006, 2:275-285.
24. Jin S.H., Yang J.H., Shin B.Y., Seo K., Shin S.M., Cho I.J., Ki S.H. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. Toxicol. Appl. Pharmacol. 2013, 271:95-105.
25. Kim J.-S., He L., Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 2003, 304:463-470.
26. Kimura R., Okouchi M., Fujioka H., Ichiyanagi A., Ryuge F., Mizuno T., Imaeda K., Okayama N., Kamiya Y., Asai K., Joh T. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience 2009, 162:1212-1219.
27. Kode A., Rajendrasozhan S., Caito S., Yang S.-R., Megson I.L., Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L478-L488.
28. Kwon Y.N., Shin S.M., Cho I.J., Kim S.G. Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection. Drug Metab. Dispos. 2009, 37:1187-1197.
29. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127:1109-1122.
30. Lee B.-H., Hsu W.-H., Chang Y.-Y., Kuo H.-F., Hsu Y.-W., Pan T.-M. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Free Radic. Biol. Med. 2012, 53:2008-2016.
31. Lee J.H., Budanov Andrei V., Talukdar S., Park Eek J., Park Hae L., Park H.-W., Bandyopadhyay G., Li N., Aghajan M., Jang I., Wolfe Amber M., Perkins Guy A., Ellisman Mark H., Bier E., Scadeng M., Foretz M., Viollet B., Olefsky J., Karin M. Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. Cell Metab. 2012, 16:311-321.
32. Lemasters J.J., Nieminen A.-L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. BBA Bioenerg. 1998, 1366:177-196.
33. Lemasters J.J., Nieminen A.L. Mitochondrial oxygen radical formation during reductive and oxidative stress to intact hepatocytes. Biosci. Rep. 1997, 17:281-291.
34. Leonard S.S., Xia C., Jiang B.-H., Stinefelt B., Klandorf H., Harris G.K., Shi X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003, 309:1017-1026.
35. Morgan P.E., Sheahan P.J., Pattison D.I., Davies M.J. Methylglyoxal-induced modification of arginine residues decreases the activity of NADPH-generating enzymes. Free Radic. Biol. Med. 2013, 61:229-242.
36. Mukohda M., Okada M., Hara Y., Yamawaki H. Exploring mechanisms of diabetes-related macrovascular complications: role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility. J. Pharmacol. Sci. 2012, 118:303-310.
37. Ogawa S., Nakayama K., Nakayama M., Mori T., Matsushima M., Okamura M., Senda M., Nako K., Miyata T., Ito S. Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension 2010, 56:471-476.
38. Pfluger P.T., Herranz D., Velasco-Miguel S., Serrano M., Tschöp M.H. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9793-9798.
39. Pun P.B.L., Logan A., Darley-Usmar V., Chacko B., Johnson M.S., Huang G.W., Rogatti S., Prime T.A., Methner C., Krieg T., Fearnley I.M., Larsen L., Larsen D.S., Menger K.E., Collins Y., James A.M., Kumar G.D.K., Hartley R.C., Smith R.A.J., Murphy M.P. A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetes. Free Radic. Biol. Med. 2014, 67:437-450.
40. Rabbani N., Godfrey L., Xue M., Shaheen F., Geoffrion M., Milne R., Thornalley P.J. Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes. Diabetes 2011, 60:1973-1980.
41. Rabbani N., Thornalley P.J. Glyoxalase in diabetes, obesity and related disorders. Semin. Cell Dev. Biol. 2011, 22:309-317.
42. Ramasamy R., Yan S.F., Schmidt A.M. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann. N. Y. Acad. Sci. 2011, 1243:88-102.
43. Ramasamy R., Yan S.F., Schmidt A.M. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vasc. Pharmacol. 2012, 57:160-167.
44. Ray S., Dutta S., Halder J., Ray M. Inhibition of electron flow through complex I of the mitochondrial respiratory chain of Ehrlich ascites carcinoma cells by methylglyoxal. Biochem. J. 1994, 303:69-72.
45. Ren J., Pulakat L., Whaley-Connell A., Sowers J. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med. 2010, 88:993-1001.
46. Rojas A., Morales M.A. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci. 2004, 76:715-730.
47. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212:167-178.
48. Rubiolo J.A., Mithieux G., Vega F.V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 2008, 591:66-72.
49. Ruggiero-Lopez D., Lecomte M., Moinet G., Patereau G., Lagarde M., Wiernsperger N. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem. Pharmacol. 1999, 58:1765-1773.
50. Sale S., Verschoyle R.D., Boocock D., Jones D.J.L., Wilsher N., Ruparelia K.C., Potter G.A., Farmer P.B., Steward W.P., Gescher A.J. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4[prime]-tetramethoxystilbene. Br. J. Cancer 2004, 90:736-744.
51. Sanchis-Gomar F. Sestrins: novel antioxidant and AMPK-modulating functions regulated by exercise?. J. Cell. Physiol. 2013, 228:1647-1650.
52. Sanli T., Linher-Melville K., Tsakiridis T., Singh G. Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. PLoS One 2012, 7:e32035.
53. Seo K., Ki S.H., Shin S.M. Methylglyoxal induces mitochondrial dysfunction and cell death in liver. Toxicol. Res. 2014, (in press).
54. Shin B.Y., Jin S.H., Cho I.J., Ki S.H. Nrf2-ARE pathway regulates induction of Sestrin-2 expression. Free Radic. Biol. Med. 2012, 53:834-841.
55. Shin S.M., Cho I.J., Kim S.G. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3β inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol. Pharmacol. 2009, 76:884-895.
56. Shinohara M., Thornalley P.J., Giardino I., Beisswenger P., Thorpe S.R., Onorato J., Brownlee M. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest. 1998, 101:1142-1147.
57. Uchino E., Fukushima T., Tsunoda M., Santa T., Imai K. Determination of rat blood S-d-lactoylglutathione by a column-switching high-performance liquid chromatography with precolumn fluorescence derivatization with 4-fluoro-7-nitro-2,1,3-benzoxadiazole. Anal. Biochem. 2004, 330:186-192.
58. Vaziri H., Dessain S.K., Eaton E.N., Imai S.-I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
59. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
60. Yki-Järvinen H. Glucose toxicity. Endocr. Rev. 1992, 13:415-431.
61. Yu T., Robotham J.L., Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2653-2658.
62. Zhang Y., Luo Z., Ma L., Xu Q., Yang Q., Si L. Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int. J. Mol. Med. 2010, 25:729-734.